The trajectory of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key markets has introduced considerable uncertainty . Investors are now grappling with the effect of generic compet